Reversible Silencing of Cytomegalovirus Genomes by Type I Interferon Governs Virus Latency by Dag, Franziska et al.
Reversible Silencing of Cytomegalovirus Genomes by
Type I Interferon Governs Virus Latency
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Abstract
Herpesviruses establish a lifelong latent infection posing the risk for virus reactivation and disease. In cytomegalovirus
infection, expression of the major immediate early (IE) genes is a critical checkpoint, driving the lytic replication cycle upon
primary infection or reactivation from latency. While it is known that type I interferon (IFN) limits lytic CMV replication, its
role in latency and reactivation has not been explored. In the model of mouse CMV infection, we show here that IFNb blocks
mouse CMV replication at the level of IE transcription in IFN-responding endothelial cells and fibroblasts. The IFN-mediated
inhibition of IE genes was entirely reversible, arguing that the IFN-effect may be consistent with viral latency. Importantly,
the response to IFNb is stochastic, and MCMV IE transcription and replication were repressed only in IFN-responsive cells,
while the IFN-unresponsive cells remained permissive for lytic MCMV infection. IFN blocked the viral lytic replication cycle by
upregulating the nuclear domain 10 (ND10) components, PML, Sp100 and Daxx, and their knockdown by shRNA rescued
viral replication in the presence of IFNb. Finally, IFNb prevented MCMV reactivation from endothelial cells derived from
latently infected mice, validating our results in a biologically relevant setting. Therefore, our data do not only define for the
first time the molecular mechanism of IFN-mediated control of CMV infection, but also indicate that the reversible inhibition
of the virus lytic cycle by IFNb is consistent with the establishment of CMV latency.
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Introduction
Herpesviruses are characterized by their ability to establish a
lifelong latent infection in their natural host and reactivate upon
immunosuppression. Cytomegaloviruses (CMV) are paradigmatic
b-herpesviruses, characterized by strict species specificity, but
highly prevalent in numerous mammalian species [1]. Human
CMV (HCMV) prevalence ranges from 30 to 90% [2]. While
primary infection and latency are usually asymptomatic in
immunocompetent individuals, immune suppression results in
virus reactivation, which is associated with substantial morbidity
and mortality. In particular, CMV reactivation may result in
allograft rejection, pneumonia or gastroenteritis in recipients of
solid-organ and bone-marrow transplants [3]. Understanding the
molecular mechanisms involved in the establishment and main-
tenance of latency is fundamental for developing effective
countermeasures to CMV disease in high-risk populations.
The human and the murine CMV (MCMV) share many
biological properties. As such, MCMV infection of mice is a widely
used in vivo model of CMV immunity and latency. Latency is
characterized by the persistence of silenced virus genomes in the
absence of infectious viral particles [4]. Both HCMV and MCMV
infect a variety of cell types in their respective host [5,6], but
latency seems to be confined to distinct cell types, such as cells of
the myeloid lineage [5,7–10]. While HCMV latency in endothelial
cells remains controversial [11,12], strong evidence supports the
notion that liver sinusoidal endothelial cells (LSECs) are a site of
MCMV latency [13].
Similar to HCMV, chromatinization and recruitment of cellular
repressors to the viral DNA and to the major immediate early
(MIE) gene locus are critically involved in the in vivo establishment
of MCMV latency [14,15]. The IE genes regulated by the MIE
promoter (MIEP) encode the first viral proteins expressed during
productive infection, and act as essential transactivators of early
and late genes [16]. Reactivation of latent HCMV from in vivo
infected myeloid progenitor cells was shown to be related to MIE
chromatinization [17]. Namely, the latent viral genome is
associated with repressive chromatin in immature myeloid cells,
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whereas virus reactivation is accompanied by chromatin remod-
eling and initiation of transcription at the MIE locus during cell-
differentiation. Therefore, MIEP transcriptional activity is gener-
ally considered an important checkpoint in CMV latency and
reactivation.
In the immunocompetent host, primary infection is controlled
by a combination of immunological effectors. Infected cells are
directly eliminated, e.g. by cytotoxic effects of NK or T-cells. In
addition, the spread of infectious virus is restricted by antibodies or
by cytokines that reduce the permissiveness of cells for viral
replication. Cytokines such as type I (IFNa/b) or type II
interferons (IFNc) are critical in the control of acute infection
[18,19]. They exert their antiviral action by activating immune
effector cells like DCs, T cells or NK cells, but also by inducing
transcriptional programs which suppress virus replication in target
cells [20].
While it is generally accepted that interferons limit virus spread
without killing the infected cell, the exact mechanism of their
antiviral action remains unclear. Most importantly, it remains
unclear if their effect results in CMV clearance, or if the viral
replication is merely suppressed while genomes are maintained in
the infected cell. A reversible block of viral replication prior to
immediate-early expression would argue that interferons play a
key role in the establishment of CMV latency. In a seminal paper,
Presti et al. showed that mice that lack type II IFN receptors
maintain a productive MCMV infection and that MCMV
reactivation from explants of latently infected mice may not be
observed in the presence of IFNc [19]. Unfortunately, this
experimental setting could not differentiate if the IFNc truly
suppresses virus reactivation by acting directly in latent cells or
merely inhibited viral spread to other cells upon reactivation. In
contrast, the role of type I IFN in the establishment and
maintenance of latency is difficult to investigate in vivo, as IFNa/
b receptor knockout (IFNAR2) mice are about 1000-folds more
susceptible to MCMV than wild-type mice, and die within a few
days post infection [19]. Nevertheless, in vitro experiments showed
that IFNb induced by lymphotoxin a reversibly suppresses
HCMV and MCMV gene expression and replication [21].
Moreover, MCMV replication in macrophages is transiently
suppressed by synergic action of IFNc and type I interferons [22].
However, both publications showed that the suppression was only
partial, because viral gene expression was reduced, but still
detectable [21,22]. Therefore, the effects of this axis seemed to
reflect simmering lytic replication, rather than bona fide viral
latency.
In this study, we show that MCMV replication may be
completely, but reversibly, inhibited in cells that respond to IFNb,
in a manner consistent with viral latency. On the other hand, cells
which failed to respond to IFNb were permissive for MCMV
replication. We show that the inhibition of MCMV replication by
IFNb depends on the inhibition of viral gene expression at the
level of IE transcription mediated by nuclear domain 10 (ND10)
components, which is fully reversible even after extended culture
of in vitro infected cells and in cultures of endothelial cells derived
from latently infected mice. In summary, our data indicate that
reversible silencing of viral genomes by IFN-induced ND10
components is a key contributor to the establishment of CMV
latency.
Results
Restriction of MCMV Replication by IFNb
LSECs are a site of MCMV latency [13]. We recently described
an LSEC line which enters cell cycle in a doxycycline-dependent
manner and is highly permissive for MCMV infection [23]. To
study type I interferon (IFN) effects on MCMV replication in
quiescent LSECs, growth-arrested cells were incubated with IFNb
for 24 h, infected with MCMV at a multiplicity of infection (MOI)
of 0.001 and viral growth was assayed for a week. Until 5 days post
infection (dpi), infectious virus was only exceptionally detected in
supernatants (SN) of IFNb-treated LSECs, and viral titers were
substantially diminished on 6 and 7 dpi, as compared to untreated
cells (Figure 1A). Therefore, consistent with previous reports, IFNb
treatment resulted in delayed viral growth and reduced viral titers,
but did not completely block MCMV replication.
Recently, we reported that a minor proportion of cells remain
unresponsive even to high doses of type I interferon [24]. We
speculated that MCMV infection of IFNb-unresponsive cells may
generate sufficient amounts of virus to overcome the barrier to
infection installed by IFNb pre-treatment. In that case, infection at
low MOI would increase the chance that exclusively IFN-
responsive cells are infected and that the infection becomes fully
contained. We thus repeated the initial experiment with reduced
doses of MCMV, up to a dilution of 1 plaque forming unit (PFU)
per 10,000 cells, and monitored the long-term IFNb effects for up
to 19 dpi in growth-arrested LSECs (20,000 cells/well). While
IFNb treated samples infected at an MOI of 0.1 and 0.01 showed
substantial virus titers by 7 dpi and later (Fig. 1B, upper panels),
MCMV replication was completely abrogated, when the infection
was performed at MOIs below 0.01 (Fig. 1B, lower panels). It is
important to note that both an MOI of 0.001 and 0.0001 still
resulted in complete cell lysis and high viral titers in IFNb-naı̈ve
samples (Fig. 1B, lower panels, white bars). These findings were
consistent with the model that CMV infection is contained at very
low MOIs because it is restricted to IFNb-responsive cells. To
confirm this hypothesis, we used reporter cells that express an IRF-
7-mCherry fusion protein under the control of the IFNb-responsive
IRF-7 promoter (Figure 2A). Reporter cell stimulation with IFNb
(500 U/ml) revealed a small but notable population of non-
responding cells (Figure 2B). We separated the cells into responders
and non-responders by fluorescence activated cell-sorting (FACS)
and then infected them with a dose (MOI 0.01), which could not be
Author Summary
Cytomegalovirus (CMV) is a widespread herpesvirus that
establishes a détente with the host immune system.
Therefore, the CMV reactivates from latency in immuno-
compromised hosts, resulting in life-threatening disease of
the vulnerable patients. However, the exact mechanism by
which the immune system keeps CMV at bay remains
incompletely understood. To address this question, we
have used a reporter system, based on infection of cells
with the mouse CMV. Our results showed that interferon
(IFN), a well-known antiviral protein, blocks CMV replica-
tion at the earliest stages after the virus has entered the
cell. More importantly, removing the IFN from the infected
cells restarted MCMV replication, indicating that its effects
are consistent with viral latency. We showed that IFN
blocked virus replication by inducing the expression of
proteins located in the nuclear domain 10 (ND10), a
compartment in the nucleus of cells to which the incoming
viral genomes are directed. Similarly, IFN was sufficient to
block CMV reactivation from cells of latently infected mice.
In conclusion, IFN had the ability to drive CMV into a
quiescent state matching the formal definition of latency
and was sufficient to prevent reactivation of bona fide
latent CMV.
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contained by IFNb in the previous experiment (Figure 1B). In the
absence of further IFNb treatment, MCMV titers were diminished
in cells which responded to IFNb (Figure 2C, left diagram). More
importantly, virus replication was completely abolished upon
continuous IFNb treatment, but only in IFNb-responsive cells
(Figure 2C, right diagram). In summary, these experiments
demonstrate that IFNb pretreatment is sufficient to restrict MCMV
replication in cells which respond to IFNb. However, virus
expansion in the few IFN-unresponsive cells eventually overcomes
the resistance of the IFNb-responsive population.
IFNb Silencing of MCMV Immediate Early Gene
Expression Is Reversible
IFNb abrogated productive MCMV replication in LSECs at
low MOIs. To elucidate at which step of infection this block was
exerted, we infected LSECs with a recombinant MCMV that
Figure 1. IFNb restricts MCMV replication in LSECs. LSECs were incubated for 24 h in medium with (+IFNb, 500 U/mL) or without IFNb (2IFNb),
and infected with MCMV. The same medium was added following infection. (A) Supernatants (SN) from cells infected at an MOI 0.001 were collected
daily up to 7 dpi and titrated on IFNAR2/2 MEFs. The average titers (PFU/mL) from triplicates are shown and error bars indicate SD. (B) LSECs were
MCMV infected at indicated MOIs and J of the SN was harvested for titration at 7, 11, 14 and 19 dpi, and substituted with medium 6 IFNb. Titration
was performed on IFNAR2/2 MEFs. Histograms show average titers (PFU/mL) from replicates 6 SD.
doi:10.1371/journal.ppat.1003962.g001
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expresses two different fluorescent proteins as reporters that reflect
the activity of the MCMV major immediate early promoter
(MIEP). This virus was named MCMVr and contains an
ectopically inserted, full-length MIEP sequence flanked by the
yellow fluorescent protein EYFP, driven by the ie1/3 promoter,
and the red fluorescent protein tdTomato that is controlled by the
ie2 promoter. MCMVr grows like WT MCMV in vitro and
expresses EYFP and tdTomato with the same scale and kinetics
like the MCMV IE1 and IE2 genes, respectively [23]. To
determine the onset of viral infection we monitored EYFP
expression, which occurs earlier than tdTomato [23], in line with
reports that the ie1 gene is immediately expressed at high levels
during primary lytic infection and reactivation [25,26]. MCMVr
infection of LSECs resulted in strong EYFP-expression, which was
hardly detectable in IFNb-treated cells (Figure 3A). To determine
if IFNb completely abrogated MCMV IE gene expression, LSECs
were infected with MCMVr in 96-well plates, scanned for reporter
gene expression, and wells were classified as positive when even a
single EYFP-fluorescent cell could be observed within a week of
infection (representative result of an experiment in 12 wells per
condition is shown in Figure 3B). Different IFNb concentrations
were tested with various MOIs, to assess the conditions that allow
the complete suppression of viral genes, and the percentage of
positive wells was defined (Figure 3C). 500 and 100 U/mL of
IFNb blocked all viral gene expression in more than 80% of wells
at 0.001 and 0.0001 MOI for 7 dpi, whereas 10 U/mL showed
similar activity only at the lower MOI (Figure 3C). Importantly, in
wells that showed one single positive cell, the progress of the lytic
infection was irreversible and the virus would always spread to
nearby cells. We next tested if the suppressive effect of IFNb on
MCMV gene expression is permanent or reversible, by removing
IFNb at 7 dpi and monitoring the cells for additional 12 days.
Remarkably, IFNb removal resulted in viral gene expression
(Figure 3D) and production of infectious virus (Figure 3E) about 7–
10 days later, while the percentage of EYFP positive wells
remained unchanged (Figure 3D) and viral titers undetectable
Figure 2. MCMV replication is completely blocked in IFNb-responsive cells. NIH3T3 cells expressing the IRF7–mCherry fusion protein were
treated with 500 U/mL IFNb for 24 h and analyzed for mCherry expression by both fluorescence microscopy and flow cytometry. Representative
microscopic pictures (A) and flow cytometry (B) of IFNb-treated (white histogram) and untreated (grey histogram) cells are shown. (C) IRF7 reporter
cells were cultured in the presence of IFNb for 24 h and FACS sorted as responder (mCherry+) or non-responder (mCherry2) cells. Both cell
populations were cultivated in absence (left), or presence of IFNb (right), infected with MCMV Dm157 eGFP at 0.01 MOI. SN were collected at 0 (input
virus), 2, 4 and 6 days post infection (dpi). Virus titrations were performed on IFNAR2/2 MEFs. Graphs show average titers (PFU/mL) of three
independent experiments 6 SEM.
doi:10.1371/journal.ppat.1003962.g002
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(Figure 3E) in wells permanently treated with IFNb. We concluded
that IFNb reversibly suppresses MCMV replication before or at
the time of MIEP-driven gene expression. Of note, the same
finding was observed following infection with the c-herpesvirus
MHV68 (Figure S1B). In contrast, vesicular stomatitis virus (VSV),
which could be efficiently suppressed with IFNb, was not able to
replicate after IFNb-retraction (Figure S1A). In conclusion, IFNb
silenced the replication of three different viruses. However, this
was only reversible for infections with the two herpesviruses.
IFNb Acts at the Level of MIEP-Driven Gene Expression
IFNb reversibly inhibited MCMV replication and expression of
genes driven by the ie1/3 promoter. This could be due to a direct
block of IE-gene expression, or effects that occurred during the
viral entry into the cells. To test if the reversible suppression by
IFNb occurs after the virus has entered the cell and the viral
genomes are delivered to the nucleus, we generated a recombinant
MCMV in which the ie1/3 locus is flanked by two loxP sites (IE1/
3flox MCMV) which results in IE1 and IE3 deletion when the
genome is recognized by the Cre recombinase in the cell nucleus
(Figure S2A). Importantly, IE1/3flox MCMV replicates in Cre-
expressing cells, probably due to rapid MIEP-driven gene
expression, which precedes the Cre-mediated deletion of target
sites (Figure 4A and Figure S2B). We considered that the Cre
recombinase would have sufficient time to excise the IE1 and IE3
genes and abrogate reactivation upon IFNb retraction, if IFNb
blocked viral gene expression after genome delivery to the nucleus.
Cre-expressing MEFs were pre-treated with IFNb, infected with
IE1/3flox MCMV or WT MCMV and the wells were scanned for
viral plaques. Viral replication of WT and IE1/3flox MCMV was
efficiently blocked in cells which constantly received IFNb over a
time period of 4 weeks (Figure 4A). IFNb removal at 7 dpi resulted
in virus replication in several wells infected with WT MCMV,
consistent with the data obtained from MCMVr-infected LSECs
(Figure 3D). In contrast, IE1/3flox MCMV failed to replicate upon
IFNb removal from Cre-MEFs, indicating that the IE1/3flox
MCMV genomes were exposed to Cre-recombinase in the
nucleus, and the deletion of the ie1/3 genes abrogated the ability
of the virus to replicate upon IFNb-removal.
Since our data indicated that MCMV genomes are delivered to
the cell nucleus in the presence of IFNb, we assumed that it
directly inhibits viral gene expression. To test the ability of IFNb to
impair viral gene expression in absence of virion components, we
delivered the MCMV genomes into cells by transfection [27].
Since transfection is less efficient in LSECs than in MEFs (data not
shown), we transfected MEFs with the MCMVr bacterial artificial
chromosome (BAC) and treated them with IFNb immediately
upon transfection. MIEP-driven expression was detected by
fluorescence microscopy for EYFP expression. Four days post
transfection, EYFP was observed in all wells transfected in the
absence of IFNb treatment. In contrast, EYFP could be observed
in only few of the IFNb-treated wells (Figure 4B). Most
importantly, removing IFNb resulted in the restoration of MIEP
activity by day 6 (Figure 4B). To understand if the inhibition of
gene expression was exclusive to the MIEP promoter, or to any
incoming DNA, fibroblasts were transfected with plasmids
expressing the EYFP and tdTomato under the control of the
MCMV MIEP or with plasmids expressing reporter genes under
Figure 3. Inhibition of viral replication by IFNb is reversible and occurs prior to immediate-early gene expression. LSECs were treated
with IFNb for 24 h and infected with MCMVr. (A) Representative EYFP fluorescence microscopy of IFNb treated (500 U/mL) or untreated LSECs at
7 dpi; MOI = 0.0001 is shown. (B) Twelve wells per condition were analyzed at multiple time points of infection. Wells containing as little as a single
infected cell were classified as positive. (C) Cells were treated with 10, 100 or 500 U/mL of IFNb for 24 h, infected at the indicated MOIs and the
percentage of positive wells (of 12) was determined at 7 dpi. Histograms indicate average values from three independent experiments, error bars
show SD. (D) IFNb-treated LSECs were infected with an MOI of 0.0001. At dpi 7, IFNb was removed in selected wells (+/2 IFNb) and wells were
monitored for EYFP expression at the indicated time points post IFN retraction. The gain of positive wells as mean percentage from three
independent experiments 6 SEM is shown. (E) LSECs were pre-stimulated with 500 U/mL IFNb and infected with 0.001 MOI of MCMVr. SN were
collected on 7, 11, 14 and 19 dpi and titrated on MEFs. Graphs show average titers (PFU/mL) from duplicates (6 SD). See also Figure S1.
doi:10.1371/journal.ppat.1003962.g003
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the control of other promoters (SV40 and HCMV). The
expression of all reporter genes was substantially diminished in
IFNb treated cells (Figure 4C and data not shown), indicating that
IFNb suppresses gene expression in a manner that is not specific
for the MCMV MIEP but to any incoming DNA. Together, these
data provide strong evidence that IFNb-mediated reversible
suppression of viral replication occurs directly at the level of gene
transcription of foreign DNA entering the nucleus.
The Suppression of Immediate Early Gene Expression by
IFNb Is Due to Transcriptional Silencing Mediated by
ND10 Components
To formally show that IFNb blocks MCMV replication at the
level of gene transcription rather than translation, we analyzed the
viral transcriptome of IFNb-treated LSECs immediately upon
MCMV infection. CMV particles carry significant amounts of
virion-associated RNA [28], which, upon delivery to infected cells,
impede the detection of de novo synthesized immediate early and
early viral transcripts. We therefore metabolically labeled newly
transcribed RNA with 4-thiouridine (4sU), isolated the labeled
RNA by thiol-specific biotinylation and streptavidin-precipitation
[29], and deep-sequenced the newly transcribed RNA. To observe
the effect of IFNb at the earliest possible time point after the
infection, we adapted the infection protocol and incubated the
cells with infectious virus for 5 min only, using an infectious dose
that was normalized to match an MOI of 10 in standard infection
and virus absorption. This allowed us to focus our analysis on viral
transcripts generated during the first hour of infection (hpi). At
1 hpi, the IE gene transcripts were detectable and comprised the
majority of viral transcripts, whereas they were highly diminished
in IFNb-treated LSECs (Figure 5A and Table S1). It is important
to note that IFNb treatment also diminished all other viral
transcripts that could be detected at 1 hpi, consistent with the
observed global suppression of reporter gene expression in all
tested expression plasmids. Thus, IFNb acts at the level of MCMV
gene transcription, resulting in strong transcriptional repression of
all viral genes expressed in the first hour of infection.
Since IFNb inhibited MCMV replication at the level of viral IE
gene transcription we hypothesized that this effect might be
mediated by induction of nuclear domain 10 (ND10) components.
Figure 4. IFNb suppresses MCMV immediate early gene expression and not virus entry. (A) MEF expressing Cre recombinase were treated
with IFNb and infected with WT or IE1/3flox MCMV (0.0001 MOI). At 7 dpi, IFNb was removed in selected wells (6 IFNb) or resupplied at regular
intervals until day 28 (+IFNb). Control cells were infected in the absence of IFNb (2IFNb). The mean percentage of wells showing viral plaques 6 SEM
at indicated time points from three independent experiments is shown. (B) MEFs were transfected with the MCMVr BAC and supplied with IFNc 5 h
later. After 4 days, the wells were inspected for signs of EYFP expression and wells were either resupplied with IFNb (+IFNb) or, in selected wells, it
was removed from the cell medium (6 IFNb). Wells were reassessed for EYFP-expression at 6 days post transfection. The percentage of positive wells
showing EYFP-expression from two independent experiments (6 SD) is shown. (C) NIH3T3 fibroblasts were transfected with a plasmid expressing
EYFP and tdTomato driven by the MCMV MIEP promoter. The cells were treated with IFNb at 5 h post transfection and analyzed by fluorescence
microscopy and flow cytometry at 3 days post transfection. Representative fluorescent images are shown and histograms indicate the percentage of
transfected cells (EYFP+tdTomato) from triplicates (6 SD). See also Figure S2.
doi:10.1371/journal.ppat.1003962.g004
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ND10 bodies are nuclear structures known to associate with
incoming viral DNA restricting CMV replication [30–32]. Hence,
we screened the host-cell transcriptome for members of the ND10
and compared their transcriptional level in untreated and IFNb-
treated LSECs. Interestingly, three major components of the
ND10: Daxx, Sp100 and PML, were upregulated in IFNb-treated
LSECs (Figure 5B and Table S2), consistent with published data
[33,34]. This was confirmed by immunofluorescence staining for
Daxx (Figure 5C) and RT-PCR for all three components (Figure
S3). To define the relevance of these factors in the IFNb-mediated
suppression of MCMV replication, we performed shRNA-
mediated knockdowns of these three ND10 components, which
reduced their mRNA levels to those seen in IFN-untreated cells
(Figure S3). More importantly, each of the three knockdowns was
sufficient to almost completely restore MCMV replication in the
presence of IFNb (Figure 5D). Collectively, these data highlight a
Figure 5. IFNb suppresses MCMV IE gene expression at the transcriptional level by inducing ND10 genes. LSECs were treated with
medium 6 IFNb (500 U/mL) and 24 h later infected with MCMV WT. Virus absorption was restricted to 5 minutes to improve time resolution. Nascent
RNA samples were collected at 1 hpi and used for deep-sequencing. (A) Histograms show normalized reads of viral transcripts in IFNb-treated and
untreated LSECs from two replicates. The fraction of the viral transcriptome corresponding to ie1, ie2 or ie3 transcripts is indicated (B) Counts of
normalized Daxx, Sp100 and PML transcripts in IFNb-treated and non-treated LSECs. Histograms show normalized reads from two replicates (C) LSECs
were treated with 10, 100 or 500 U/mL IFNb or left untreated for 24 h and then stained for Daxx. Representative fluorescent pictures are shown. (D)
LSECs were transfected with plasmids expressing shRNA against Daxx, Sp100 or PML, treated with IFNb or left untreated and infected 24 h later with
0.01 MOI of MCMVr. Control cells were transfected with scrambled shRNA in the presence or absence of IFNb and infected as above. Viral plaques
were counted 4 dpi, normalized to represent IFNb-untreated samples as 100 and average normalized PFU from three independent experiments 6 SD
are shown. See also Figure S3 and Table S1, S2 and S3.
doi:10.1371/journal.ppat.1003962.g005
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key role of ND10 bodies in the transcriptional silencing of CMV
gene expression induced by IFNb.
IFNb Induces a Reversible Silencing of MCMV In Vivo
While our results showed very clear IFNb effects on MCMV
lytic replication, it remained open if it also induces MCMV latency
in vivo. To understand how MCMV infection influences the
production IFNb in vivo, we infected transgenic mice which carry a
luciferase reporter gene under the control of the MX2 promoter
[35], a well-characterized IFN stimulated gene (ISG). Luciferase
activity could be detected in the MCMV-infected mice already at
4 hpi (Figure 6A), indicating immediate production of IFN upon
MCMV infection (Figure 6A). The reporter gene signal peaked at
12 hpi and declined thereafter, although a robust luciferase signal
could still be detected by 72 hpi (Fig. 6A, 6B). Interestingly, the
response to IFN was most prominent in the liver region
throughout the time of monitoring.
To determine if in vivo IFNb-stimulation also transiently silences
MCMV in LSECs, we infected mice with MCMVr in which the
production of IFNb was induced prior to infection. For this, we
used a previously described IFN-b reporter mouse (IFN-b+/Db-luc),
allowing the visualization of IFNb expression by in vivo imaging
using firefly luciferase as a reporter [36]. These mice were
stimulated with poly I:C and a high activity of the IFNb promoter
could be detected 4 h after poly I:C injection but not in mock
treated mice (Figure S4), consistent with the kinetic of MCMV
infection (Fig. 6A). Mice were infected with MCMVr at 8 h post
stimulation, and LSECs were isolated from the liver of the infected
mice at 72 hpi. LSECs were cultivated for 7 days and analyzed for
reporter gene expression at 1, 4 and 7 days post isolation. After 1
day, MCMV reporter gene expression (EYFP) could be detected in
all of the wells with LSECs that were isolated from control mice,
infected in the absence of poly I:C. In contrast, MCMV ie gene
expression was absent in about 1/3 of the wells containing LSECs
from poly I:C-stimulated mice (Figure 6C). This was not merely a
random redistribution of the EYFP+ cells to fewer wells, because
the overall number of EYFP+ cells was substantially reduced in
LSECs from poly I:C treated mice (Figure 6D). We considered the
possibility that the absence of viral gene expression upon in vivo
IFN induction is a result of a hindered viral entry in the LSECs.
Figure 6. IFNb stimulation in vivo induce a reversible silencing of MCMV in LSECs. (A) Whole-body in vivo imaging of luciferase activity
upon intraperitoneal infection of Mx2Luc reporter mice with 16106 pfu MCMV WT. Control mice were mock infected with PBS. The rainbow scale
depicts the strength of radiance expressed as photons per second per cm2 per steradian (sr). Imaging was performed at 4, 12, 24, 48 and 72 hpi. (B)
Quantification of luciferase activity by region of interest (ROI) analysis of the liver. Two independent experiments were performed with similar results;
one representative experiment is shown. Mean values of two mock- and three MCMV-infected mice are shown and error bars indicate SD (C, F) LSECs
were isolated from MCMVr infected IFNb-reporter mice at 72 hpi and dispensed in a 96-well plate (28 replicates per condition). The wells were
monitored for EYFP expression and the percentage of EYFP+ wells at day 1 post isolation (C) or the kinetic on days 1, 4 and 7 (F) is shown. (D, G) EYFP+
LSECs were counted and normalized to positive events per 100.000 cells. Mean values and SEM at day 1 (D) post isolation, or the kinetic on day 1, 4
and 7 (G) are shown. (E, H) Supernatants from isolated LSECs were collected and titrated on MEFs. The graph shows the mean and SEM of triplicates
on day 1 post isolation (F) or the dynamic monitoring at days 1, 4 and 7 post isolation (G).
doi:10.1371/journal.ppat.1003962.g006
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However, this scenario seemed unlikely, because we could not
detect any infectious MCMV in the supernatants from poly I:C
pre-treated LSEC (Figure 6E), while control LSECs showed
detectable titers, probably as a result of ongoing virus shedding in
the first 24 hours of culture. To understand if the in vivo MCMV
suppression by IFN was due to reversible silencing of gene
expression, the cells isolated from poly I:C-treated mice were
further cultivated and MCMV gene expression was monitored at 4
and 7 days post isolation and EYFP expression could be observed
in all of the wells, including those that were negative at 1 day post
isolation (Figure 6F). Likewise, the number of EYFP+ cells
increased upon cultivation, and by 4 and 7 days post isolation
the LSECs from poly I:C treated mice showed similar levels as the
controls (Figure 6G). Finally, this was accompanied by full virus
reactivation, as demonstrated by the emergence of infectious virus
in the supernatants at 4 days post isolation in the IFNb-stimulated
LSECs, and by its expansion by day 7 (Figure 6H). In conclusion,
the infection of LSECs stimulated with IFNb in vivo increased the
proportion of cells that contained silent MCMV genomes that
were able to re-initiate the replication cycle after explantation,
upon several days of ex vivo cultivation. To confirm that this also
occurs in the course of natural infection, in wild type mice and in
absence of poly I:C treatment, we isolated LSECs from BALB/c
mice at 72 hpi infection with MCMVr and monitored EYFP
expression on day 1 and 4 post isolation. By seeding LSECs at a
lower concentration per well (50,000 cells per well, instead of
70,000), and using mice expressing IFNb from both of its alleles
(luciferase expression in reporter IFN-b+/Db-luc mice is possible due
to a monoallelic exclusion of IFNb expression), we established
conditions where MCMV IE gene expression was completely
Figure 7. IFNb represses MCMV reactivation from in vivo infected LSECs. LSECs were isolated from MCMVr infected mice at 4 weeks p.i. and
cultivated for up to 3 weeks. (A) LSECs were inspected by fluorescence microscopy for reporter gene expression. Typical microscopic pictures
observed at 4, 6 and 11 days post isolation are shown. (B, C) Primary LSECs from MCMVr infected mice were cultivated with 500 U/mL IFNb (+IFNb) or
left untreated (2IFNb). In selected wells of IFN-treated LSECs, IFNb was removed from the cell medium at 6 days post isolation (6 IFNb). (B)
Percentage of wells showing EYFP expression at indicated days post isolation, expressed as average 6 SEM from triplicates. (C) SN were collected on
indicated days post isolation and titrated for infectious MCMV on IFNAR2/2 MEFs. Graphs show average titers of triplicates (PFU/mL) 6 SEM.
doi:10.1371/journal.ppat.1003962.g007
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abrogated in absence of poly I:C prestimulation, because 7 out of
26 wells showed no EYFP expression at all on day 1 post isolation.
The majority of these wells (5 out of 7) became positive for EYFP
by day 4 post isolation (data not shown), demonstrating that viral
genomes, but no gene expression, were present in some cells
immediately upon infection. These silenced genomes may re-
initiate the lytic gene expression program, therefore strongly
arguing that viral latency is established in parallel with lytic
replication at the onset of the in vivo infection.
IFNb Represses MCMV Reactivation from In Vivo Infected
LSECs
IFNb reversibly silenced MCMV gene expression in LSECs
infected in vivo and in vitro, a phenomenon with intriguing
homologies to MCMV latency and reactivation. To determine if
IFNb would be sufficient to suppress MCMV reactivation from
LSECs carrying latent viral genomes, and to define if this would
also occur at the level of immediate-early gene expression, we
infected mice with MCMVr and isolated the LSECs from the liver
of latently infected mice. Infectious MCMVr is completely cleared
from liver by 14 dpi [23]. Primary LSECs were isolated at 4 weeks
post infection and cultivated for up to three weeks in vitro. Viral
gene expression was monitored by fluorescence microscopy for
EYFP expression. After 6 days of cultivation, the LSEC explant
monolayers displayed single fluorescent cells (Figure 7A). Within a
couple of days, the infection expanded resulting in numerous
fluorescent cells. The majority of wells with LSECs that were
cultivated in presence of IFNb exhibited no viral gene expression
(Figure 7B). In contrast, IFNb removal at 6 days post LSEC
isolation resulted in a strong increase of EYFP-positive wells,
almost to levels seen in the IFN-naive controls (Figure 7B), thereby
excluding the suppressive effects of IFNb to be due to toxic effects.
Finally, infectious virus shedding in the cell supernatants was
confirmed only in IFN-untreated cells or upon IFNb removal
(Figure 7C). In summary, these data demonstrate that IFNb is not
only able to efficiently inhibit lytic MCMV infection following pre-
treatment, but can also efficiently suppress MCMV reactivation of
latently infected primary LSECs.
Discussion
It is well-established that IFNb inhibits lytic CMV replication, but
cannot abrogate it completely [37,38]. Recently, we reported that
even high doses of IFNb cannot activate all cells of a population,
leaving a few cells unprotected [24]. We now show that this minority
of cells is responsible for the failure of IFNb to completely abrogate
lytic MCMV replication. Consequently, MCMV gene expression
and replication are completely blocked by IFNb at very low doses of
infection, when the probability of infection of an IFNb-unresponsive
cell is minimized. Higher doses of infectious MCMV are blocked
when infecting sorted IFN-responder cells (Fig. 2). Restricting the
infection to IFN-responsive cells allowed us to identify the reversible
nature of the IFN-mediated inhibition of CMV replication. This
could not be observed in previous studies, because viral IE gene
expression in a single cell is sufficient to overcome IFNb-induced
resistance to viral replication in subsequent rounds of infection. This
all-or-nothing phenotype is consistent with a model where the initial
failure to contain the expression of IE1 results in a positive feedback
loop, which reinforces viral transcription that can no longer be
controlled by IFNb [39,40]. Large amounts of virus released from a
single IFN-unresponsive cell are then capable of overcoming the
antiviral state in the neighboring IFN-responder cells explaining the
inability of IFN to fully suppress productive CMV infection in cell
culture.
Consistent with this model, expression of the viral IE1 protein is
crucial for the dispersion of ND10 bodies, thereby allowing
transcription of viral early genes to proceed [41]. Several
components of the ND10 bodies, are induced by IFN. ND10
were initially described as the nuclear domains where HCMV
genomes are localized immediately upon infection [42]. Subse-
quent studies revealed that HCMV replication is inhibited by
additive effects of ND10 components, including PML, Daxx [43]
and Sp100 [44]. Daxx has been shown to be involved in
chromatin modification [45,46] and was found to bind to the
MIEP of MCMV in latently infected mice [14]. In addition, a role
in transcriptional suppression has been suggested for the nuclear
antigen Sp100 which was shown to repress the transcriptional
activity of herpes simplex virus 1 (HSV-1) promoters [47]. We
showed here that IFNb-mediated inhibition of MCMV replication
critically depends on the ND10 proteins PML, Daxx and Sp100,
rather than on any other IFN induced gene (Figure 5). Our study
supports a critical role of ND10 bodies in limiting the viral
transcription at the earliest stages of infection, and shows for the
first time that this is fully reversible, and thus consistent with the
molecular definition of latency. Therefore, we propose that the
virus exploits the IFN-mediated induction of ND10 body
components to establish latent infection in tissues strongly
responding to IFN. In this context, herpesvirus latency may be
understood as an immune evasion mechanism to high levels of
IFN, because latency offers a choice for the virus to maintain its
ability to reactivate in an environment with rampant immune
responses until these responses decline.
Our data highlight a crucial role of IFNb-mediated induction of
ND10 components, similar to previous data showing the critical
role of PML in the IFN repression of HSV-1 replication [48]. Our
results are not necessarily limited to the establishment of latency in
endothelial cells. Similar results have been recently observed in
macrophages, where interferon induced ND10 expression and an
MCMV refractory state at the IE expression level (M. Hassim and
P. Ghazal, personal communication). Therefore, IFN may also be
involved in the induction of latency in myeloid cells, and it is an
intriguing possibility that this may also depend on the induction of
ND10 bodies. How do the ND10 bodies silence the viral
transcription? Our results may imply that the silencing is not
based on the suppression of a specific promoter, but rather of any
incoming episomal DNA, although this still needs to be formally
confirmed. More importantly, our results showed that a complex
nuclear machinery is required for MCMV silencing, because each
of the shRNA knockdowns (Daxx, Sp100 or PML) were sufficient
to rescue viral transcription, at least in part. Taken together, these
results may imply that ND10 bodies silence viral transcription in a
manner akin to programmed epigenetic control, but this
hypothesis would need to be tested in a detailed study, which
goes beyond the scope of this article.
IFNb was not only able to completely inhibit lytic MCMV
replication in vitro and in vivo, but also to prevent virus reactivation
from latency in explant cultures. Since both IFNa and IFNb signal
through the same receptor and induce a range of similar genes, it is
possible that both type I IFNs exert similar effects on MCMV
latency [38,49,50]. On the other hand, recent evidence showed
distinct differences in the downstream signaling induced by IFNb
and IFNa [51]. Furthermore IFNb induces the secretion of IFNa
in mice [52] and therefore it is possible that in our experiments the
IFNb-stimulation does not act directly, but rather by enforcing the
secretion of other antiviral cytokines which may influence MCMV
latency. Either way, it is unlikely that the amounts of type I IFNs
which are necessary to keep the virus in check in vitro are produced
over a prolonged time in the latently infected host, and this is also
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inconsistent with our kinetic monitoring of IFN responses upon
MCMV infection (Fig. 6A and 6B). However, it is conceivable that
individual LSECs which respond to type I IFNs generate a
reservoir of latently infected cells. Once viral latency has been
established, immune control may well be exerted by primed T and
NK cells [53]. These cells are activated later during the infection
process, but persist longer than type I IFN secreting cells and both
have the potential to secrete IFNc, and thus control lytical CMV
replication [19]. MCMV specific effector T-cells are readily
detectable in organs of latently infected mice [54], arguing for a
strong and ongoing recruitment of immune cells to sites of virus
latency, and thus for an active role of the immune system in the
prevention of CMV reactivation. An additional layer of control
may also result from epigenetic silencing of the viral genomes once
latency has been established [10,15]. In line with a model of
epigenetic control of viral transcription, which acts on top of IFNb
mediated transcriptional suppression, IE gene expression restarted
with a delay, and could only be observed approximately one week
upon IFNb retraction (Fig. 3D, 7B).
In conclusion, our study establishes a link between type I IFN
signaling, ND10 bodies and reversible suppression of CMV
transcription and strongly argues for their key role in the
establishment of herpesviral latency.
Materials and Methods
Ethics Statement
All animal experiments were performed in compliance with the
German animal protection law (TierSchG BGBI S. 1105;
25.05.1998). The mice were handled in accordance with good
animal practice as defined by FELASA and GV-SOLAS. All
animal experiments were approved by the responsible state office
(Lower Saxony State Office of Consumer Protection and Food
Safety) under permit number 33.9-42502-04-11/0426.
Cells
M2-10B4 (CRL-1972; ATCC) and NIH 3T3 fibroblasts (CRL-
1658; ATCC) were maintained in Dulbecco’s modified Eagle
medium supplemented with 10% fetal calf serum, 1% Glutamine
and 1% Penicillin/Streptomycin. Primary C57BL/6, IFNAR2/2
and CMV-Cre MEFs were prepared and maintained as described
previously [55]. Conditionally immortalized LSECs were gener-
ated and cultivated as described [23]. NIH3T3 IRF7-mCherry
were generated and characterized previously [24].
Mice
All mice were bred at the animal facility of the Helmholtz
Centre for Infection Research (HZI) and maintained under
specific pathogen-free conditions. Conditional deletion/reporter
mice IFN-bfloxb-luc and Mx2Luc reporter mice were generated and
characterized previously [35,36].
Viruses
MCMV clones were grown on M2-10B4 cells and partially
purified as described [56], with the following modification: upon
ultracentrifugation, the virus pellet was resuspended in 1.2 ml of
Virus standard Buffer (0.05 M Tris, 0.012 M KCl, 0.005 M
EDTA) and centrifuged in a microcentrifuge for 5 minutes at
30006g. The clear supernatant was harvested, aliquoted and
stored at 280uC. The BAC-derived wild-type MCMV (MCMV
WT) [57] and MCMVr [23] have been described previously. The
230 kb MCMV BAC Dm157 eGFP was generated by homologous
recombination of a linearized PCR fragment expressing the eGFP
gene under the control of the minimal CMV promoter into the
m157 genomic region of the pSM3fr BAC, essentially as described
[58]. In brief, the gene was inserted by a two-step mutagenesis
procedure, where in the first step the gene was introduced into the
BAC, along with a kanamycin resistance gene (kan) flanked by frt
sites, at nucleotide positions 216291 to 216874, thus replacing
most of the m157 gene, including its start codon. In a subsequent
step, kan was excised by transient expression of flip recombinase,
and recombined clones were selected by kanamycin sensitivity,
thus generating the Dm157/eGFP pSM3fr plasmid. The recom-
binant virus MCMV IE1/3flox contains two loxP sequences which
flank the open reading frames of the immediately early genes ie1
and ie3 and is a derivative of MCMV WT [57]. MCMV IE1/3flox
was generated by two-step recombination mutagenesis using the
galK selection system and modified to include antibiotic resistance
selection in the first mutagenesis step [59]. A linear PCR-derived
recombination fragment encoding galK and kanamycin resistance
(KanR) was amplified from the pGPS/galKn plasmid [59] using
primers P9 and P11 (for primer and construct sequences see
supplementary table S4), inserted into SW102 E. Coli carrying the
MCMV WT BAC genome and recombined BAC clones were
selected on kanamycin plates. The synthetic DNA construct C1
(Geneart) was subsequently introduced, replacing the GalK/Kan
gene with a loxP site at nucleotide position 177965–177974
according to the published MCMV genome annotation [60]. The
second loxP-site was inserted with the same method, using primers
P43 and P45 in the first mutagenesis step and the synthetic DNA
product C2 (Eurofins MWG Operon) inserted in the second step
at nucleotide position 182837–182846. The entire sequence of the
final BAC clone was sequenced in an Illumina sequencer to
exclude illegitimate recombination events. The newly generated
BACs were transferred into MEFs and reconstituted viruses grown
as described above. VSV-GFP [61] and MHV68 GFP [62] were
grown as described previously.
MCMV Growth Kinetics
Confluent monolayers of non-cycling LSECs or NIH3T3 were
infected with MCMV WT or MCMVr at the Multiplicity of
infection (MOI) of 0.1. After 1 h, the cells were washed with PBS,
supplied with fresh medium and incubated for 6 days. SN were
harvested in triplicates and stored at 270uC until they were
titrated on MEFs.
IFNb-Treatment and Virus Infections
Confluent monolayers of non-cycling LSECs were infected in
96-well plates with MCMVr, MHV68 GFP or VSV GFP at
indicated MOIs. LSECs were treated with recombinant mouse
IFNb (PBL Interferon Source, Piscataway, NJ) as follows: (1)
untreated LSECs (2IFNb) were cultivated with normal medium
throughout the experiment. (2) IFNb-treated LSECs (+IFNb) were
stimulated 24 h before the infection and supplied with IFNb
throughout the experiment. (3) LSECs, in which the IFNb was
retracted (+/2IFNb) were stimulated 24 h before the infection
and cultivated for 7 days in the presence of IFNb. At 7 dpi, the
IFN-containing medium was exchanged with normal medium and
cells were cultivated without IFNb until the end of the experiment.
For all conditions, the cells were supplied with fresh medium every
2–3 days. Infected cells were monitored by Fluorescence
Microscopy for reporter gene expression at the indicated time
points and wells that showed viral replication indicated by
fluorescent cells, were classified as positive.
Immunofluorescence
LSECs were cultivated on chamber slides (Thermo Scientific)
and stimulated for 24 h with IFNb. The cells were stained with
Type I IFN Governs Cytomegalovirus Latency
PLOS Pathogens | www.plospathogens.org 11 February 2014 | Volume 10 | Issue 2 | e1003962
Daxx (clone 25C12; 1:25) rabbit mAb (Cell Signaling) according to
the manufacture’s protocol. In brief, cells were fixed with
Formaldehyde, permeabilized with Triton-X-100 and anti-rabbit
Alexa 488 (clone B13C; 1:200) was used as secondary antibody.
The cells were mounted with VECTASHIELD (Vector Labora-
tories) prior to microscopic analysis.
In Vivo Infection and Reactivation Assay
6 to 10 weeks old C57BL/6 mice (Janvier) were intraperitone-
ally infected with 106 PFU of MCMVr and housed in SPF
conditions throughout the experiment. Initial isolation of mouse
liver non parenchymal cell (NPC) was performed according to a
published protocol [63]. In brief, liver was perfused with 5 ml liver
perfusion medium (Gibco-Invitrogen, Paisley, UK) and with 5 ml
liver digestion medium (Gibco-Invitrogen, Paisley, UK). Upon
removal of the liver from the mouse, the liver was cut in small
pieces, incubated for 30 min in liver digestion medium and gently
pressed through a Nylon 100 mm cell strainer (BD Falcon). Cells
up from five livers were pooled, washed in PBS, resuspended in
40% Percoll (Biochrom), gently overlaid onto 70% Percoll, and
centrifuged at 7506 g for 20 min. NPC collected from the
interface were washed twice and resuspended in PBS/1%FCS.
Upon red blood cell lysis, LSECs were isolated from NPCs by
immunomagnetic sorting. For this purpose, cells were counted and
resuspended in 10 ml of antimouse-CD146–conjugated magnetic
beads (Miltenyi Biotec) and 90 ml of PBS+1% FCS per 107
nucleated cells, incubated for 15 minutes at 4uC and magnetically
separated according to the manufacturer’s protocol. Isolated
LSECs were maintained in RPMI supplemented with 10% fetal
bovine serum (FBS) (PAN Biotech, Aidenbach Germany),
penicillin (100 U/mL), streptomycin (100 mg/mL), L-glutamine
(2 mM), 1 mM sodium pyruvate and 0.2 mM 2-mercaptoethanol
(Gibco-Invitrogen, Paisley, UK) on plates coated with 0.5% gelatin
(Sigma, St. Louis, MO, USA). Cells were seeded and cultivated in
an incubator at 37uC, 7% CO2 and 5% O2, at maximal humidity.
LSECs were treated with recombinant mouse IFNb and
monitored by fluorescent microscopy for signs of virus reactivation
as detailed above. For plaque assay, LSECs were treated with
recombinant mouse IFNb (PBL Interferon Source, Piscataway,
NJ) as described above with the following modifications: LSECs
were treated with 100 U/mL and the IFNb was removed after
seven days of cultivation. Triplicate SN were stored at 270uC and
titrated on IFNAR2/2 MEFs.
Cell Sorting
NIH3T3 IRF7-mCherry cells were stimulated with IFNb
(500 U/mL). The cells were trypsinized 24 h later, resuspended
in PBS and sorted in mCherryhigh and mCherrylow populations
using a FACS Aria II (BD Bioscience) cell sorter.
Stimulation and of IFNb-Reporter Mice and In Vivo
Imaging
For the stimulation of IFN-b+/Db-luc mice, poly I:C (100 mg/
mouse) was injected i.v. or the mice were mock injected with PBS
only. To visualize the reporter gene in IFN-b+/Db-luc and Mx2-luc
mice, the mice were injected i.v. with 150 mg/kg of D-luciferin in
PBS (Calipers), anesthetized using Isofluran (Baxter) and moni-
tored using an IVIS 200 imaging system (Calipers). Photon flux
was quantified using the Living Image 3.0 software (Calipers).
Overlays were analyzed using the Living Image 4.1 software.
Relative intensities of emitted light were presented as pseudocolor
overlays ranging from red (most intense) to black (least intense).
Data were expressed as radiance, quantified as photons/sec/cm2/
sr. Steradian (sr) refers to the photons emitted from a unit of solid
angular measure.
Deep Sequencing of Nascent RNA and Transcriptome
Analysis
Cells were treated with IFNb (500 U/ml) for 24 h prior to
infection. Cells were infected with WT MCMV at a nominal MOI
of 1. Virus was allowed to absorb for 5 minutes at 2000 rpm in a
tissue culture centrifuge and was removed immediately thereafter,
which increases the infectivity rate by a factor of 10 as compared to
cells infected with the same amount of virus for 1 h, in the absence of
centrifugation (See Figure S5). Importantly, this increased the time
resolution to the 5 minutes of virus absorption. The labeling and
isolation of nascent RNA was performed for 1 h as described [29],
and biological duplicates of the transcriptome (100 ng of nascent
RNA per sample) were used for TruSeq RNA Library construction
using TruSeq RNA sample preparation kit (Low-Throughput
protocol) according to manufacturer’s protocol. The final amplified
library was purified using AMPure XP Beads (Agencourt). Quality
of TruSeq Libraries were checked using Agilent Technologies 2100
Bioanalyzer and run on Genome Analyzer IIx (Illumina Inc.) in
single end mode with length of 36 nt per read.
The program BWA [64] was used to align the reads to a reference
genome composed of the mouse genome (version mm10) with the
MCMV genome (NC_004065.1) inserted as an extra chromosome.
Reads were read into the R statistical language version 2.15 [65]
counted, and evaluated with the R package edgeR [66] following
the edgeR tutorial. Annotation for the mouse was downloaded using
the GenomicFeatures R package (available from the Bioconductor
website) from the UCSC database, while viral annotation was
created from the NCBI Genbank NC_004065 GFF file using
GenomicFeatures. Mouse and virus data were analysed both
separately and together, and reads per kilobase per million (RPKM)
values were generated. Significantly differently expressed genes
were determined by edgeR using two replicates.
shRNA-Mediated Knockdown and Reverse Transcription
PCR
shRNAs-sequences targeting murine DAXX, SP100, and PML
or non-coding (NC) shRNA were generated by using the online
tool from Integrated DNA Technologies (IDT) or the database
from the RNAi-consortium. Design of shRNA-vector inserts for of
pRNA-U6/Neo (GeneScript #SD1201) was performed according
to the manufacturer’s manual. Sense and antisense siRNA
sequences were ordered as loop-sequences annealed before
ligation into the shRNA-vector. Single clones were selected and
sequenced. Both Sense and Antisense sequences of the used
shRNAs are listed in Table S3. LSECs were transfected with 2 mg
plasmid DNA encoding for shRNA targeting Daxx, SP100, PML
or a non-targeting control-shRNA. 24 h following transfection,
medium was exchanged by RPMI supplemented with IFNb
(500 U/mL), incubated for 24 h upon which the RNA was
extracted from cells with TRIzol (Invitrogen), according to the
manufacturers protocol. cDNA was synthesised with SyperScript
II (Invitrogen) and oligo(dT)12–18 primers according to manufac-
turer’s recommendation. qRT-PCR for genes of interest was
performed using peqGOLD REAL-TIME (Peqlab) and SYBR
Green in a LightCycler 480 (Roche) and the results were
normalised to GAPDH.
Supporting Information
Figure S1 IFNb reversibly blocks the replication of
MHV68 and not VSV. LSECs were infected with (A) 1 MOI
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of VSV-GFP or (B) 0.0001 MOI MHV68-GFP in the presence
(+IFNb, 100 or 500 U/mL) or absence of IFNß (2IFNb). After
7 dpi, IFNb was removed from the medium (+/2 IFNb) and wells
were screened and classified as positive for GFP expression until
17 dpi. The percentages of wells showing cells with GFP
expression are indicated. Graphs show the mean of three
independent experiments and error bars indicate SEM.
(TIF)
Figure S2 The loxP sites in MCMV IE1/3flox are
recognized by Cre recombinase. (A) MEFs expressing
inducible Cre recombinase (Cre.ERT2) were cultured for 48 h in
presence of 1 mM Tamoxifen to induce it. The cells were infected
with the salivary gland homogenates from MCMV IE1/3flox or
MCMV WT-infected mice. After additional 48 h the supernatant
was harvested and used to analyse the ie1/3 gene locus for
recombination by PCR with primers P18 and P47 (see
supplementary table S4) flanking the ORF of ie1/3. The first lane
shows the negative control (N), the second lane the DNA ladder
and the third lane shows the PCR product from the MCMV WT
BAC (BAC). The experiment was done with samples from three
different mice for each virus. (B) CMV-Cre and WT MEFs were
infected with 0.1 MOI MCMV IE1/3flox, supernatants were
collected from 0 to 6 dpi and titrated on MEF cells. Graph show
the mean values of triplicates (6 SD).
(TIF)
Figure S3 shRNA-mediated knockdown of ND10 com-
ponents. LSECs were transfected with plasmids encoding
shRNAs targeting Daxx, Sp100, PML or a non-targeting
control-shRNA (ctrl). The medium was exchanged after 24 h to
RPMI supplemented with 500 U/mL IFNb where indicated.
After 24 h RNA was extracted and cDNA synthesised. qRT-PCR
was performed in a LightCycler 480 using SYBR Green staining.
The transcripts of interest were quantified by standard dilutions
with cDNA encoding vectors and normalised to GAPDH.
(TIF)
Figure S4 Induction of IFNb in vivo after poly I:C
administration. (A) Whole-body in vivo imaging of luciferase
activity upon injection of IFNb-reporter mice (IFN-b+/Db-luc) with
poly I:C (100 mg/mouse) or PBS. The rainbow scale depicts the
strength of radiance expressed as photons per second per cm2 per
steradian (sr). Imaging was performed at 4 hours post infection
(hpi). (B) Bars shows the quantification of luciferase activity by
region of interest (ROI) analysis of the liver at 4 hpi from five mice
and error bars indicate SD.
(TIF)
Figure S5 Centrifugation enhances infectivity of
MCMV. LSECs were infected with 0.1 MOI MCMVr using
centrifugal enhancement of 5 min at 800 g or incubated for 1 h at
37uC. The medium was exchanged after the centrifugation or the
1 h-incubation and replaced with normal culture medium.
Histograms show the percentage of EYFP-expressing cells as
analyzed by flow cytometry after 3 dpi.
(TIF)
Table S1 Regulation of viral genes in IFNb-treated
LSECs. Normalised counts of MCMV genes expressed in non-
treated (2 IFN) and treated (+ IFN) LSECs (stimulated with
500 U/mL IFN for 24 h) after 1 hpi. The presented numbers
represent RPKM (Reads per kilo base per million), to normalise
the reads for the length of the gene.
(XLSX)
Table S2 Regulation of cellular genes in IFNb-treated
LSECs. Normalised counts of cellular genes expressed in non-
treated (2 IFN) and treated (+ IFN) LSECs (stimulated with
500 U/mL IFN for 24 h). The presented numbers represent
RPKM (Reads per kilo base per million), to normalise the reads
for the length of the gene.
(XLSX)
Table S3 List of shRNA sequences. The sense and antisense
sequences that were used for the shRNA-expressing plasmids
(described in detail in Material and Methods).
(XLSX)
Table S4 Primer and construct sequences. The sequences
of the primers and constructs that were used to generate the
recombinant MCMV IE1/3flox (Generation is described in detail
in Material and Methods).
(XLSX)
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